Has James San Filippo, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,672 in general payments to James San Filippo, MD across 94 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean James San Filippo, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about James San Filippo, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

James San Filippo, MD

Dermatology · Westerville, OHNPI 1417992314

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,907 of the $2,672 with a category attached, or 71.4%. It is spread thinly across 24 manufacturers, the largest accounting for just 19.6%. 2025 is the largest year on record at $1,768, more than ten times the $161 reported in 2019. That places this record below the midpoint for dermatology clinicians in OH, where the typical reported total is $2,374.

$2,672in general payments, 2019–2025

Across 94 payments — averaging $28.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

VB Spine LLC$524
AbbVie$507
Medtronic$477
Pfizer$230
E.r. Squibb & Sons, L.L.C.$126
Novartis$88
plus $719 from 18 others

What the payments were for

Travel & lodging$74928%
Food & beverage$1,90771%
Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
VB Spine LLC	3	$524
AbbVie	27	$507
Medtronic	3	$477
Pfizer	15	$230
E.r. Squibb & Sons, L.L.C.	5	$126
Novartis	4	$88
Galderma Laboratories, L.p.	3	$81
Regeneron Healthcare Solutions, Inc.	4	$74
Arcutis Biotherapeutics, Inc.	4	$70
Organon	3	$66
Sanofi	3	$55
Almirall LLC	2	$48
Lilly USA, LLC	2	$43
Johnson & Johnson	3	$42
Incyte Corporation	2	$41
Sun Pharmaceutical Industries Inc.	2	$35
Biofrontera Inc.	2	$31
LEO Pharma Inc.	1	$28
VYNE Pharmaceuticals Inc.	1	$27
Boehringer Ingelheim	1	$19
Novum Pharma, LLC	1	$17
Bristol Myers Squibb	1	$16
Dermavant Sciences, Inc.	1	$14
Genentech USA, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CASCADIA INTERBODY SYSTEM$506
MAZOR X SYSTEM$407

How this compares

$2,672 in reported general payments places this provider in the 50th percentile of 460 dermatology providers in Ohio.

See all dermatology providers in Ohio →

Medicare billing

Part B allowed, 2024

$247,423

Medicare patients

1,018

Services billed

3,728

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	16	$70,621
Ketoconazole	512	$7,634
Fluorouracil	60	$4,775
Clobetasol Propionate	101	$4,477
Fluocinonide	45	$1,839
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc	130	$1,784
Metronidazole	29	$1,482
CiclopiroxCiclopirox Olamine	52	$1,407
Triamcinolone Acetonide	163	$1,311
Famciclovir	28	$572
Cephalexin	33	$544
Clindamycin Phosphate	13	$526
Doxycycline Hyclate	18	$514
Doxycycline Monohydrate	28	$455
Dapsone	15	$343

Paid to pharmacies, not to this prescriber.

Other dermatology in Westerville

Joshua GrosshandlerWesterville$479K
Rosina LinWesterville$17K
Matthew ZirwasBexley$3.3M
George DrewMarion$1.9M
Rocco SerraoDayton$1.7M
James LibeccoFairlawn$1.1M
Pranav ShethWest Chester$978K
Dawn MerrittAthens$844K
Neil KormanCleveland$824K
Lorie GottwaldToledo$460K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →